{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:06:27Z","timestamp":1772762787780,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010511","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000}}],"reference-count":57,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010511.pub2","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T17:20:55Z","timestamp":1503422455000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer"],"prefix":"10.1002","volume":"2017","author":[{"given":"Balamurugan A","family":"Vellayappan","sequence":"first","affiliation":[{"name":"National University Hospital; Department of Radiation Oncology; 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore Singapore 119228"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Yang","family":"Soon","sequence":"additional","affiliation":[{"name":"National University Hospital; Department of Radiation Oncology; 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore Singapore 119228"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey Y","family":"Ku","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center; Gastrointestinal Oncology Service; 300 East 66th Street New York NY USA 10065"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Nang","family":"Leong","sequence":"additional","affiliation":[{"name":"National University Hospital; Department of Radiation Oncology; 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore Singapore 119228"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiade J","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Proton and Heavy Ion Center (SPHIC); 4365 Kang Xin Road Pudong New District Shanghai China 201321"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy CS","family":"Tey","sequence":"additional","affiliation":[{"name":"National University Hospital; Department of Radiation Oncology; 1E Kent Ridge Road NUHS Tower Block, Level 7 Singapore Singapore 119228"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD010511.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD010511.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl033","article-title":"A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer","volume":"17","author":"Bonnetain","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.gcb.2007.12.026","article-title":"Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive","volume":"32","author":"Burtin","year":"2008","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"31","key":"10.1002\/14651858.CD010511.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1200\/JCO.2007.12.3471","article-title":"Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9102","volume":"25","author":"Crehange","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD010511.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ejca.2015.05.027","article-title":"Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone","volume":"51","author":"Vincent","year":"2015","journal-title":"European Journal of Cancer"},{"issue":"10","key":"10.1002\/14651858.CD010511.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0007|cit7","unstructured":"ISRCTN 89052791 Feasibility trial of chemoradiation or surgery for oesophageal cancer isrctn.com\/ISRCTN89052791 10.1186\/ISRCTN89052791"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"vii79","DOI":"10.1093\/annonc\/mdv471.01","article-title":"Comparison between NAC-S and CRT in overall survival for patients with esophageal squamous cell carcinoma (JCOG1406-A)","volume":"26 (suppl 7)","author":"Nomura","year":"2015","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010511.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/JTO.0b013e31802bff75","article-title":"A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer","volume":"2","author":"Wang","year":"2007","journal-title":"Journal of Thoracic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010511.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000658-200208000-00005","article-title":"Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus","volume":"236","author":"Altorki","year":"2002","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010511.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011498.pub2","article-title":"Non-surgical versus surgical treatment for oesophageal cancer","author":"Best","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010511.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/annonc\/mdl033","article-title":"A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer","volume":"17","author":"Bonnetain","year":"2006","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010511.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010511.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.gcb.2007.12.026","article-title":"Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive","volume":"32","author":"Burtin","year":"2008","journal-title":"Gastroenterologie Clinique et Biologique"},{"issue":"5","key":"10.1002\/14651858.CD010511.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005","volume":"101","author":"Cook","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemo-radiotherapy of locally advanced esophageal cancer: long term follow up of a prospective randomized trial (RTOG 85-01)","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010511.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"30","author":"Cox","year":"1995","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"31","key":"10.1002\/14651858.CD010511.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1200\/JCO.2007.12.3471","article-title":"Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9102","volume":"25","author":"Crehange","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0020|cit20","unstructured":"Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2006 August ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf"},{"issue":"7305","key":"10.1002\/14651858.CD010511.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD010511.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD010511.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: a systematic review","volume":"5","author":"El-Serag","year":"2007","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1056\/NEJMsa1010705","article-title":"Trends in hospital volume and operative mortality for high-risk surgery","volume":"364","author":"Finks","year":"2011","journal-title":"New England Journal Of Medicine"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0025|cit25","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"7414","key":"10.1002\/14651858.CD010511.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa022343","article-title":"Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus","volume":"347","author":"Hulscher","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SLA.0b013e3182a1b11d","article-title":"A decade analysis of trends and outcomes of partial versus total esophagectomy in the United States","volume":"258","author":"Jafari","year":"2013","journal-title":"Annals of Surgery"},{"issue":"13","key":"10.1002\/14651858.CD010511.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3748\/wjg.v16.i13.1649","article-title":"Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma","volume":"16","author":"Jin","year":"2010","journal-title":"World Journal of Gastroenterology"},{"issue":"27","key":"10.1002\/14651858.CD010511.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1148\/rg.292085106","article-title":"Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy","volume":"29","author":"Kim","year":"2009","journal-title":"RadioGraphics"},{"issue":"1","key":"10.1002\/14651858.CD010511.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gtc.2009.01.012","article-title":"Preoperative therapy for esophageal cancer","volume":"38","author":"Ku","year":"2009","journal-title":"Gastroenterology Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD010511.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD010511.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010511.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10552-009-9458-0","article-title":"Increasing trend of the incidence of esophageal squamous cell carcinoma but not adenocarcinoma in Taiwan","volume":"21","author":"Lu","year":"2010","journal-title":"Cancer Causes and Control"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010511.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1470-2045(07)70172-9","article-title":"Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities","volume":"8","author":"Mariette","year":"2007","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/bjs.1800770804","article-title":"Surgical therapy of oesophageal carcinoma","volume":"77","author":"Muller","year":"1990","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/oxfordjournals.annonc.a059237","article-title":"Is surgery necessary with multimodality treatment of oesophageal cancer","volume":"6","author":"O'Reilly","year":"1995","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000658-199909000-00012","article-title":"Transhiatal esophagectomy: clinical experience and refinements","volume":"230","author":"Orringer","year":"1999","journal-title":"Annals of Surgery"},{"issue":"24","key":"10.1002\/14651858.CD010511.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010511.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00365520600815654","article-title":"Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports","volume":"42","author":"Post","year":"2007","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12029-013-9477-7","article-title":"Chemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: Is surgical resection required?","volume":"44","author":"Rawat","year":"2013","journal-title":"Journal of Gastrointestinal Cancer"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0045|cit45","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0046|cit46","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence Cochrane Consumers and Communication Group cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/dote\/11.3.168","article-title":"Does cell type influence post-esophagectomy survival in patients with esophageal cancer","volume":"11","author":"Salazar","year":"1998","journal-title":"Diseases of the Esophagus"},{"issue":"1","key":"10.1002\/14651858.CD010511.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/annonc\/mdt342","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Stahl","year":"2013","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010511.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends: an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer","volume":"366","author":"Hagen","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010511.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010511","article-title":"Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer","author":"Vellayappan","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD010511.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ejca.2015.05.027","article-title":"Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone","volume":"51","author":"Vincent","year":"2015","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD010511.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010511.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1748-717X-6-55","article-title":"Curative treatment of oesophageal carcinoma: current options and future developments","volume":"26","author":"Wolf","year":"2011","journal-title":"Radiation Oncology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010511.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T07:32:46Z","timestamp":1676446366000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010511.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010511.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}